Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 3/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18323644 | 0.80 | KDM4E (0.55) | KDM4ESMN1; SMN2PBRM1L3MBTL1BRD4 | |
| SCHEMBL18323637 | 0.79 | KDM4E (0.41) | KDM4ESMN1; SMN2DNMT1 | |
| SCHEMBL18323651 | 0.72 | KDM4E (0.64) | KDM4ESMN1; SMN2PBRM1L3MBTL1BRD4 | |
| SCHEMBL18323647 | 0.69 | KDM4E (0.60) | KDM4ESMN1; SMN2PBRM1L3MBTL1BRD4 | |
| SCHEMBL10847889 | 0.59 | KDM4E (0.47) | KDM4ESMN1; SMN2PBRM1L3MBTL1BRD4 | |
| SCHEMBL15907080 | 0.58 | KDM4E (0.60) | KDM4EDNMT1 | |
| Methoxymethane SCHEMBL27501177 | 0.53 | ALDH1A1 (0.53) | SMN1; SMN2ACHEALDH1A1TSHR | |
| SCHEMBL21720224 | 0.53 | — | — | |
| SCHEMBL11919886 | 0.52 | ALDH1A1 (0.48) | KDM4ESMN1; SMN2L3MBTL1ACHEALDH1A1 | |
| SCHEMBL9197048 | 0.51 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9522910-B2 | Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon | Obshchestvo s ogranichennoy otvetstvennostyou “Fusion Pharma” (RU) | 2016-12-20 | — | — | US | disclosed |